Abstract
Ventral incisional hernia is one of the most common log-term surgical complications after open midline surgeries and accounts for almost 20–30% of the cases [1, 2]. Repair of this incisional hernia is always challenging for general surgeons, especially for complex abdominal wall hernia (CAWH) which also have a major physical, social, and mental repercussions on patients [3]. Ramirez et al. devised a component separation technique (CST) which aims medicalization of rectus abdominis muscles by complete division of bilateral external oblique aponeurosis [4].
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Introduction
Ventral incisional hernia is one of the most common log-term surgical complications after open midline surgeries and accounts for almost 20–30% of the cases [1, 2]. Repair of this incisional hernia is always challenging for general surgeons, especially for complex abdominal wall hernia (CAWH) which also have a major physical, social, and mental repercussions on patients [3]. Ramirez et al. devised a component separation technique (CST) which aims medicalization of rectus abdominis muscles by complete division of bilateral external oblique aponeurosis [4].
CAWH is the one with large hernia defects with size >10 cm; re-recurrence; loss-of-domain; large abdominal wall/soft tissue defect and or enterocutaneous fistula; hernias in anatomically peripheral locations; and close-to-bone or local recurrent infection [4].
Recently, Surgeon’s technological armamentarium has been widened for CAWH with introduction of preoperative injection of botulinum toxin A (BTA). It is a protein with neurotoxin activity and is produced by Clostridium botulinum and has an inhibitory effect on presynaptic cholinergic nerve endings [5]. This technique was first reported by Ibarra-Hurtado et al. in 2009, where he used BTA to facilitate fascial closure in 12 patients [6]. Lateral muscle paralysis was successfully achieved for tension-free hernia defect closure. BTA gives an additional advantage of narcotic analgesia with due action blocking the acetylcholine and also by preventing the release of substance P from presynaptic motor nerve endings [7]. Although BTA is a dangerous chemical, small well-calculated doses at specific points on abdominal wall, and also by avoiding vital muscles and viscera have good safety profile [7, 8].
Botulinum Toxin
Types, Mechanism, Effects, and Duration of Action
Commercially available brands of BTA are Botox® (Fig. 1) and Dysport®. This protein blocks the release of acetylcholine in nerve terminals and paralyzes the muscles.
BTA is injected into ventral abdominal wall muscles to achieve functional denervation with paralyzing effect that starts in 3–4 days and reaches maximum effect in 2 weeks [8]. This flaccid paralysis of muscles leads to an increase in abdominal cavity volume. This helps abdominal wall reconstruction without tension. Working in close collaboration with interventional radiologists provides very promising results.
Practical Applications
Selection of Patient
Initially, we have to make certain selection criteria on the basis of which we can provide benefits to the patients. There is no consensus but little evidence on certain criteria which are published in the literature, the most important of which is the complex abdominal wall hernia repair (CAWR) according to the size and site. The average length of frontal abdominal musculature from the linea alba to midaxillary line is about 15–20 cm; and the length gained by BTA administration is 3–4 cm on each side; and 6–8 cm in total. This suggests that a defect of 6–8 cm size would likely get benefit from the best results without component separation technique and the repair would be tension free as well [9]. The author has performed a limited number of cases and more randomized trials are needed to establish the facts.
Injections and Interventional Radiological Kit
Author recommends six injections of 50 IU Botox® (Botulinum Toxin A), Sterile water for dilution, and six sets of 25G spinal needles. Ultrasound kit should include minimum of linear transducer (4–12 MHz) in sterile housing; chlorhexidine can additionally be used as a coupling agent (Fig. 2).
Selection of Site
The site of BTA is crucial and needs to be defined very accurately. Elstner, Ibarra-Hurtado, Zielinski, and Zandejas have described four different techniques but with one end result. They concluded that BTA administration between midclavicular and midaxillary line pattern could be of a straight line or triangular from costal margin to superior iliac fossa [6, 10, 11]. According to Ibarra-Hurtado technique, patient is placed in left or right lateral position and five sites are identified. Two on midaxillary line at equal distance, three more on anterior axillary and midclavicular lines, and reciprocal is produced for other side as well. These techniques give advantage of increased length and decreased thickness of lateral ventral abdominal muscles (Fig. 3).
Consenting, Selection of Dose, and Procedure
Standard precautions for any interventional radiological procedure should be practiced as per national guidelines. Counseling and consenting regarding steps, and risks vs benefits should be explained in a surgical clinical visit by the surgeon first and later by interventional radiologists. Back ache once paralyzing effects of toxin on muscles should be addressed and abdominal binder therefore should be prescribed beforehand. Always explain to patient that respiration may be labored especially if undertaking heavy activity.
During the procedure, inform the patient that injections would be at various sites and not to cough or take any sudden deep breath during the procedure to avoid any injury to underlying structures. Identify three muscles [External Oblique Muscle (Ex Ob M.); Internal Oblique Muscle (In. Ob M.); and Transversus Abdominus (Tr. Ab M.) (Figs. 3 and 4)].
There is a great personal bias in the selection of dose for BTA. Doses are varying in different studies but all are aiming to decide “good effective” amount with “best” dilution at “appropriate” time at “the best” site. Some believe a larger amount (400 IU) of BTA is safe but the author suggests 150 IU on each side with a total and maximum amount of 300 IU (six injections total as mentioned above).
Recently, we have proposed even a more conservative approach to reduce the dosing amount to 100 IU on each side to a total of 200 IU for up to 10 cm defect. Equal amount of six doses at six sites (three on each side) should be administered under ultrasound guidance by an expert hand to avoid complications [9, 10]. Although the surgeons are also expert in doing this procedure; radiologists are more helpful to perform this procedure [12].
Aftermath
The author’s routine is to request interventional radiologist, master in this technique and familiar with the results and outcome, of his hospital to perform the BTA injection to the bilateral anterior abdominal wall muscles (external oblique, internal oblique, and transversus abdominis) 3 weeks before the operation. Ideal time for surgery is in third or fourth week after injections. Either laparoscopic (preferably) or lap-assisted surgery is performed when BTA provides its peak effect at 4 weeks resulting in flaccid paralysis, and then declined gradually in the next 3–4 months. During this whole time, the patient is advised to wear an abdominal binder to avoid complications which might be a result of this flaccid muscle paralysis.
Complications
A study by Nielsen et al. reported one patient who had pain related to BTA injections which was managed by narcotic pain medications and resolved prior to surgery [13].
Three more studies [11, 14, 15] reported patients reporting with weak cough or sneeze after BTA injections but their condition improved after wearing an abdominal binder [14]. In addition to this weak coughing, few patients reported with a sense of bloating that resolved after hernia repair while some others reported with backache and dyspnea which improved with abdominal binder [15]. Based on these complications, the author devised a way to reduce the amount from 300 IU to 200 IU with a rationale of sparing the transverses abdominis muscle which may allow to increase core stability and ultimately will reduce the side effects.
Conclusion
Initial results have shown BTA as a very good alternative to CST for CAWH with minor side effects. Dual advantages of tension-free hernia repair and analgesic effect have raised the interest of researchers. Additionally, flaccid relaxation of abdominal muscles decreases the intra-abdominal pressure thus improving ventilation complications and ultimately reducing the need for and duration of invasive ventilation support. These advantages further facilitate the postoperative healing process as well. All these discussions are from initial results and large randomized control studies on the dosage, techniques, and timing of BTA would be needed to reach a consensus.
References
Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, et al. Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial. Lancet. 2017;390:567–76.
Bikhchandani J, Fitzgibbons RJ Jr. Repair of giant ventral hernias. Adv Surg. 2013;47:1–27.
Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, et al. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet. 2015;386:1254–60.
Ramirez OM, Ruas E, Dellon AL. “Components separation” method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg. 1990;86:519–26.
Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991;324:1186–94.
Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, Robles-Vélez E, De Jesús G-JJ. Use of botulinum toxin type A before abdominal wall hernia reconstruction. World J Surg. 2009;33:2553–6.
Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallet M, Mayer NH. Botulinum toxin: therapeutic clinical practice and science. Philadelphia: Saunders Elsevier; 2009. p. 512.
Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol. 2012;15:325–36. https://doi.org/10.1016/j.mib.2012.05.012.
Lien SC, Hu Y, Wollstein A, Franz MG, Patel SP, Kuzon WM, Urbanchek MG. Contraction of abdominal wall muscles influences size and occurrence of incisional hernia. Surgery. 2015;158:278–88. https://doi.org/10.1016/j.surg.2015.01.023.
Weissler JM, Lanni MA, Tecce MG, Carney MJ, Shubinets V, Fischer JP. Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg. 2017;51:366–74. https://doi.org/10.1080/2000656X.2017.1285783.
Elstner KE, Read JW, Rodriguez-Acevedo O, Ho-Shon K, Magnussen J, Ibrahim N. Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. Surg Endosc. 2017;31:1914–22. https://doi.org/10.1007/s00464-016-5194-1.
Bueno-Lledó J, Torregrosa A, Ballester N, Carreño O, Carbonell F, Pastor PG, et al. Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia. Hernia. 2017;21:233–43.
Nielsen M, Bjerg J, Dorfelt A, Jørgensen LN, Jensen KK. Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain. Hernia. 2020;24:295–9.
Farooque F, Jacombs AS, Roussos E, Read JW, Dardano AN, et al. Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg. 2016;86:79–83.
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, et al. Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2018;32:831–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2023 The Author(s)
About this chapter
Cite this chapter
Malik, S., Lomanto, D. (2023). Role of Botulinum Toxin-A in Chemical Component Separation Technique. In: Lomanto, D., Chen, W.TL., Fuentes, M.B. (eds) Mastering Endo-Laparoscopic and Thoracoscopic Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-19-3755-2_62
Download citation
DOI: https://doi.org/10.1007/978-981-19-3755-2_62
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-3754-5
Online ISBN: 978-981-19-3755-2
eBook Packages: MedicineMedicine (R0)